Cargando…
Targeting Gastric Cancer with Trastuzumab: New Clinical Practice and Innovative Developments to Overcome Resistance
Autor principal: | Roukos, Dimitrios H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805793/ https://www.ncbi.nlm.nih.gov/pubmed/19841980 http://dx.doi.org/10.1245/s10434-009-0766-0 |
Ejemplares similares
-
More Controversy than Ever – Challenges and Promises Towards Personalized Treatment of Gastric Cancer
por: Liakakos, Theodore, et al.
Publicado: (2008) -
CDH1 Testing: Can it Predict the Prophylactic or Therapeutic Nature of Total Gastrectomy in Hereditary Diffuse Gastric Cancer?
por: Ziogas, Dimosthenis, et al.
Publicado: (2009) -
Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population
por: Moore, J. L., et al.
Publicado: (2022) -
Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2‐Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
por: Al‐Batran, Salah‐Eddin, et al.
Publicado: (2020) -
Minimally Invasive and Open Gastrectomy for Gastric Cancer: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials
por: Davey, Matthew G., et al.
Publicado: (2023)